Bertino JR - Search Results

1

p14ARF expression increases dihydrofolate reductase degradation and paradoxically results in resistance to folate antagonists in cells with nonfunctional p53.

Magro PG, Russo AJ, Li WW, Banerjee D, Bertino JR. Magro PG, et al. Among authors: bertino jr. Cancer Res. 2004 Jun 15;64(12):4338-45. doi: 10.1158/0008-5472.CAN-03-1045. Cancer Res. 2004. PMID: 15205349

2

mRNA expression levels of E2F transcription factors correlate with dihydrofolate reductase, reduced folate carrier, and thymidylate synthase mRNA expression in osteosarcoma.

Sowers R, Toguchida J, Qin J, Meyers PA, Healey JH, Huvos A, Banerjee D, Bertino JR, Gorlick R. Sowers R, et al. Among authors: bertino jr. Mol Cancer Ther. 2003 Jun;2(6):535-41. Mol Cancer Ther. 2003. PMID: 12813132

3

Protection of hematopoietic stem cells from pemetrexed toxicity by retroviral gene transfer with a mutant dihydrofolate reductase-mutant thymidylate synthase fusion gene.

Capiaux GM, Budak-Alpdogan T, Alpdogan O, Bornmann W, Takebe N, Banerjee D, Maley F, Bertino JR. Capiaux GM, et al. Among authors: bertino jr. Cancer Gene Ther. 2004 Dec;11(12):767-73. doi: 10.1038/sj.cgt.7700683. Cancer Gene Ther. 2004. PMID: 15359285

4

E2F-1 overexpression in U2OS cells increases cyclin B1 levels and cdc2 kinase activity and sensitizes cells to antimitotic agents.

Russo AJ, Magro PG, Hu Z, Li WW, Peters R, Mandola J, Banerjee D, Bertino JR. Russo AJ, et al. Among authors: bertino jr. Cancer Res. 2006 Jul 15;66(14):7253-60. doi: 10.1158/0008-5472.CAN-05-3725. Cancer Res. 2006. PMID: 16849574

5

Active site-directed double mutants of dihydrofolate reductase.

Ercikan-Abali EA, Mineishi S, Tong Y, Nakahara S, Waltham MC, Banerjee D, Chen W, Sadelain M, Bertino JR. Ercikan-Abali EA, et al. Among authors: bertino jr. Cancer Res. 1996 Sep 15;56(18):4142-5. Cancer Res. 1996. PMID: 8797582

6

Overexpression of p21waf1 leads to increased inhibition of E2F-1 phosphorylation and sensitivity to anticancer drugs in retinoblastoma-negative human sarcoma cells.

Li WW, Fan J, Hochhauser D, Bertino JR. Li WW, et al. Among authors: bertino jr. Cancer Res. 1997 Jun 1;57(11):2193-9. Cancer Res. 1997. PMID: 9187120

7

Role of E2F-1 in chemosensitivity.

Banerjee D, Schnieders B, Fu JZ, Adhikari D, Zhao SC, Bertino JR. Banerjee D, et al. Among authors: bertino jr. Cancer Res. 1998 Oct 1;58(19):4292-6. Cancer Res. 1998. PMID: 9766655

8

Antitumor activity of antifolate inhibitors of thymidylate and purine synthesis in human soft tissue sarcoma cell lines with intrinsic resistance to methotrexate.

Li WW, Tong WP, Bertino JR. Li WW, et al. Among authors: bertino jr. Clin Cancer Res. 1995 Jun;1(6):631-6. Clin Cancer Res. 1995. PMID: 9816025

9

Inability of leucovorin to rescue a naturally methotrexate-resistant human soft tissue sarcoma cell line from trimetrexate cytotoxicity.

Li WW, Bertino JR. Li WW, et al. Among authors: bertino jr. Cancer Res. 1992 Dec 15;52(24):6866-70. Cancer Res. 1992. PMID: 1458475

10

Mechanisms of natural resistance to antifolates in human soft tissue sarcomas.

Li WW, Lin JT, Tong WP, Trippett TM, Brennan MF, Bertino JR. Li WW, et al. Among authors: bertino jr. Cancer Res. 1992 Mar 15;52(6):1434-8. Cancer Res. 1992. PMID: 1371715

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

711 results

Search Page

Filters